Successful pregnancy requires an appropriate intrauterine immune response to the conceptus, which is a semiallograft within the uterus. We reported that swine leukocyte antigen-DQA (SLA-DQA), a major histocompatibility complex (MHC) class II gene, is expressed in the uterine endometrium at the time of conceptus implantation in pigs. Because MHC molecules play critical roles in the immune system, SLA-DQ was hypothesized to be involved in immune regulation during pregnancy. Therefore, we examined expression of SLA-DQ in uterine endometrial tissues obtained during the estrous cycle and pregnancy. SLA-DQA and SLA-DQB mRNAs were detected as 1.3-kb and 1.2-kb bands, respectively. Real-time RT-PCR analysis indicated that SLA-DQA and SLA-DQB mRNA expression was affected by day and pregnancy status, with the highest expression on Day 15 of pregnancy. SLA-DQ was localized primarily to subepithelial stromal cells and endothelial cells of the uterus. Using endometrial explant cultures from Day 12 of the estrous cycle, we determined that expression of SLA-DQA and SLA-DQB mRNAs increased in response to interferongamma (IFNG), which is produced by pig conceptus trophectoderm between Days 14 and 18 of pregnancy. The abundance of SLA-DQ protein was less in endometria from gilts with conceptuses resulting from somatic cell nuclear transfer compared with endometria from gilts with conceptuses resulting from natural mating. These results support our hypothesis that SLA-DQ is expressed in response to IFNG from the conceptus, and likely regulates immune response at the maternal-fetal interface to support the maintenance of pregnancy in pigs.
INTRODUCTION
The establishment and maintenance of pregnancy involves a series of complex process that require well-organized interactions between the maternal uterus and the conceptus (embryo/ fetus and associated extraembryonic membranes) that may be species specific [1] . The implanting conceptus is a semiallograft within the uterine environment that expresses alloantigens derived from paternal genes, but it is protected from rejection by the maternal immune system during gestation [2] . Several mechanisms may be responsible for protection of the conceptus from immune rejection by the maternal immune system and maintenance of immune tolerance during pregnancy. These include expression of monomorphic major histocompatibility complex (MHC) class I molecules by trophectoderm, intrauterine immune suppression, and expression of immunoprotective molecules by trophoblast, such as FasL (CD95L) [2] [3] [4] [5] . Although progress has been made in understanding mechanisms underlying maternal immune tolerance to the developing conceptus during pregnancy in species with invasive hemochorial placentation, the mechanism(s) is not understood in species with epitheliochorial placentation, including pigs.
The implantation process in pigs is initiated when the conceptus begins secretion of estrogen, the signal for maternal recognition of pregnancy, and various cytokines, including interleukin 1 beta (IL1B), interferon gamma (IFNG), and interferon delta (IFND) [6] . In response to those molecules of conceptus origin, as well as progesterone from corpora lutea, the uterine endometrium undergoes significant cellular and molecular changes (i.e., epithelial cell polarization, increased secretory activity of uterine glands and altered expression of endometrial genes) [7] . During placentation there is cell-to-cell contact between the uterine luminal epithelial cells (LE) and trophectoderm to form a functional placenta for exchange of nutrients, gases, and waste. Compared to species with invasive hemochorial placenta, implantation in pigs is superficial, and results only from adhesion between the uterine LE and trophectoderm/chorion during placentation [1] . This suggests that simple apposition and adhesion between the maternal uterine LE and placental trophectoderm or chorion does not evoke a response from the maternal immune system in the pig, which has a true epitheliochorial placenta [8] . Accordingly, there is likely to be some unique mechanisms for immune tolerance during pregnancy in pigs.
The maternal immune system at the maternal-fetal interface in pigs may become favorable to the developing conceptuses to ensure its survival as a semiallograft. For example, swine MHC or swine leukocyte antigen (SLA) class I molecules are not expressed by cells of the porcine placenta during pregnancy [9, 10] . In addition, classical and nonclassical SLA class I molecules (SLA-1, -2, -3, -6, -7, and -8) and b2-microglobulin are expressed by uterine LE and stromal cells during the periimplantation period of pregnancy, but their expression decreases after completion of implantation [9] . Redistribution of immune cells in response to pregnancy or the presence of conceptuses results in a decrease in numbers of uterine endometrial natural killer (uNK) cells at implantation sites, and uNK cells become localized to deeper endometrial regions in pigs [11, 12] , whereas uNK cells become more abundant during decidualization in mice and humans [11] .
The SLA class II antigens are composed of heterodimeric proteins with an a chain (34 kDa) and a b chain (29 kDa ) that  are encoded by SLA-DRA, SLA-DRB1, SLA-DQA, SLA-DQB,  SLA-DOA, SLA-DOB1 , SLA-DMA, and SLA-DMB [13] . The SLA class II antigens, DR and DQ, are expressed predominantly by antigen-presenting cells (i.e., macrophages, B cells, and dendritic cells), as well as in endothelial cells and T cells. The function of SLA class II antigens is to present exogenous peptides to CD4 þ helper T cells [13] . We reported that SLA-DQA is expressed in the uterine endometrium on Day 12 of the estrous cycle and pregnancy in pigs [14] . However, expression and regulation of SLA-DQ molecules in the uterine endometrium during pregnancy, and the function of SLA-DQ for immune regulation, are not understood.
Somatic cell nuclear transfer (SCNT) is a technique used to clone various animal species, including pigs, but the cloning efficiency to produce viable offspring is very low [15] , likely due to incomplete nuclear reprogramming of the donor nucleus in SCNT embryos [16, 17] . Uterine endometrial responsiveness to SCNT embryos is altered during pregnancy as compared to that for normally fertilized embryos [18] [19] [20] [21] . Expression of uterine endometrial genes involved in immune function is altered during the implantation peroid of cows carrying conceptuses derived by SCNT, which indicates that the maternal immune environment is a critical factor for survival of cloned embryos [21] . However, immunological characteristics of uterine endometria supporting SCNT-derived conceptuses have not been well studied in pigs.
Therefore, this study examined the immune function of SLA-DQ during pregnancy at the maternal-fetal interface in pigs. The objectives were to determine: 1) expression of SLA-DQA and SLA-DQB mRNAs in uterine endometria during the estrous cycle and pregnancy; 2) cell-specific localization of SLA-DQA and SLA-DQB mRNAs and SLA-DQ protein in the uterine endometria; 3) regulation of SLA-DQA and SLA-DQB mRNA levels by steroid hormones, estrogen and progesterone, and cytokines, IL1B and IFNG; and 4) expression of SLA-DQA and SLA-DQB in uterine endometria of pigs carrying SCNTderived conceptuses as compared to those carrying conceptuses derived from natural ovulation and mating.
MATERIALS AND METHODS

Animals and Tissue Preparation
All experimental procedures involving animals were conducted in accordance with the Guide for Care and Use of Research Animals in Teaching and Research and approved by the Institutional Animal Care and Use Committee of Yonsei University. Sexually mature cross-bred female gilts (ages between 8 and 12 mo) were assigned randomly to either cyclic or pregnancy status and hysterectomized on either Day 12 or 15 of the estrous cycle, or Day 12, 15, 30, 60, 90, or 114 of pregnancy (n ¼ 3 gilts/day/status) after the animals were slaughtered. Pregnancy was confirmed by the presence of apparently normal filamentous conceptuses flushed from the uterus on Days 12 and 15 and presence of embryos and placenta on later stages of pregnancy. Endometrium samples, dissected free from myometrium, were collected from two different areas of the middle portion of each uterine horn of each gilt. All endometrial FIG. 1. Analysis of expression of SLA-DQA (A) and SLA-DQB (B) mRNAs in the porcine uterine endometrium during the estrous cycle and pregnancy by real-time RT-PCR analysis. Analysis of endometrial tissue samples from cyclic and pregnant gilts (n ¼ 3 per day) for expression of SLA-DQA and SLA-DQB mRNAs revealed that expression of both SLA-DQA (linear effect of day, P ¼ 0.069) and SLA-DQB (linear effect of day, P , 0.05) mRNAs was greatest on Day 15 of pregnancy in least-squares regression analysis and expression on Day 15 of pregnancy was greater than for Day 15 of the estrous cycle (Day 3 status, P , 0.05 for both SLA-DQA and SLA-DQB) in least-squares ANOVA. Data are reported as expression relative to that detected on Day 12 of the estrous cycle after normalization of the transcript amount to the endogenous RPL7 control. Data are presented as least-squares means (SEM).
In situ hybridization analysis of SLA-DQA mRNA in the porcine uterine endometrium during the estrous cycle and pregnancy. SLA-DQA mRNA was localized primarily to stromal cells and blood vessels of the endometrium on all days studied. A section from adult spleen hybridized with a DIGlabeled antisense SLA-DQA cRNA probe served as a positive control, and a representative uterine section from Day 60 of pregnancy, hybridized with a DIG-labeled sense SLA-DQA cRNA probe (Sense) served as a negative control. BV, blood vessel; C, estrous cycle; CM, chorionic membrane; D, day; GE, glandular epithelial cells; LE, luminal epithelial cells; P, pregnancy; St, stroma; arrowheads, subepithelial stromal cells; arrows, blood vessels; asterisk, shown in inset at higher magnification. Bars ¼ 100 lm and 50 lm in inset.
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Endometrial tissue samples were obtained from gilts carrying embryos generated by SCNT on Days 12 and 114 of pregnancy, as described previously [19, 20] . On Day 12 of pregnancy, uterine endometrial tissues were obtained from four gilts that carried SCNT-derived conceptuses and three gilts with conceptuses resulting from natural mating. Some ovoid conceptuses were recovered from uteri of two pigs with SCNT-derived embryos, and no conceptuses were recovered from other pigs with SCNT-derived embryos. On Day 114 of pregnancy, uterine endometrial tissues were obtained from three gilts carrying SCNT-derived conceptuses without any evident clinical symptoms at C-section (classified as NT-normal), from three gilts carrying nonviable or still-born SCNT fetuses (NT-abnormal), and from three gilts carrying conceptuses resulting from natural mating (Non-NT).
For RNA extraction, endometrial tissues were snap frozen in liquid nitrogen and stored at À808C, and tissues from four different areas of uterine horn were collected and pooled for each pig with SCNT conceptuses or Non-SCNT conceptuses on Day 12 of pregnancy to reduce the possible heterogeneity of endometrial gene expression. For in situ hybridization and immunohistochemistry, cross-sections of endometria and conceptuses were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 24 h and then embedded in paraffin, as previously described [22, 23] .
Explant Cultures
Endometrium was dissected from the myometrium and placed into warm phenol red-free Dulbecco modified Eagle medium/F-12 culture medium (DMEM/F-12; Sigma, St. Louis, MO) containing penicillin G (100 IU/ml) and streptomycin (0.1 mg/ml) as described previously [24] , with some modifications. The endometrium was minced with scalpel blades into small pieces (2-3 mm 3 ), and aliquots of 500 mg were placed into T25 flasks with serum-free modified DMEM/F-12 containing 10 lg/ml insulin (catalog no. I5500; Sigma), 10 ng/ml transferrin (catalog no. T1428; Sigma), and 10 ng/ml hydrocortisone (catalog no. H0396; Sigma). Endometrial explants were cultured immediately after mincing in the presence of ethanol (control), estradiol-17b (E 2 ; 50 ng/ml; catalog no. E8875; Sigma), progesterone (P 4 ; 3 ng/ ml; catalog no. P0130; Sigma), E 2 þ P 4 , E 2 þ P 4 þ ICI182,780 (ICI; an estrogen receptor antagonist; 200 ng/ml; Tocris, Ballwin, MO), or E 2 þ P 4 þ RU486 (RU; a progesterone receptor antagonist; 30 ng/ml; catalog no. M8046; Sigma) for 24 h with rocking in an atmosphere of 5% CO 2 in air at 378C. To determine the effects of cytokines on SLA-DQA and SLA-DQB expression, endometrial explant tissues were treated with 0, 1, 10, or 100 ng/ml IL1B (catalog no. I9401; Sigma) or IFNG (catalog no. 985-PI/CF; R&D Systems, Minneapolis, MN) in the presence of both E 2 (50 ng/ml) and P 4 (3 ng/ml) at 378C for 24 h. Explant tissues were then harvested and total RNA was extracted for real-time RT-PCR analysis of SLA-DQA and SLA-DQB mRNA levels. These experiments were conducted using endometria from three gilts on Day 12 of the estrous cycle. Treatments were performed in triplicate using tissues obtained from each of the three gilts.
Total RNA Extraction and RT-PCR for SLA-DQA and SLA-DQB cDNA Total RNA was extracted from endometrial tissues using TRIzol reagent (Invitrogen Life Technology, Carlsbad, CA) according to manufacturer's recommendations. The quantity of RNA was assessed spectrophotometrically, and integrity of RNA was examined by electrophoresis in 1% agarose gel.
Total RNA (2 lg) was treated with DNase I (Promega, Madison, WI) and reverse transcribed using SuperScript II Reverse Transcriptase (Invitrogen) to obtain cDNAs. The cDNA templates were then diluted 1:5 with sterile water and amplified by PCR using Taq polymerase (Takara Bio, Shiga, Japan) and specific primers based on mRNA sequences of porcine SLA-DQA (GenBank accession no. NM_001130224; forward, 5 0 -GCC TGT GGA GGT GAA GAC AT-3 0 ; reverse, 5 0 -CAG TGC TCC ACT TTG CAG TC-3 0 ) and SLA-DQB (GenBank accession no. NM_001113694; forward, 5 0 -GCT CTA AAC CAC CAC AAC CT-3 0 ; reverse, 5 0 -CAA AAA CCA ACC CCA AAG TA-3 0 ), which amplify cDNA of 524 bp and 399 bp, respectively. PCR conditions for SLA-DQA and SLA-DQB were 35 cycles of 948C for 45 sec, 548C for 45 sec, and 728C for 1 min. PCR products were separated on 2% agarose gel and visualized by ethidium bromide staining. The identity of each amplified PCR product was verified by sequence analysis after cloning into pCRII vector (Invitrogen).
Northern Blot Analysis
Total RNA (20 lg) was loaded in each lane and electrophoresed on 1% 3-(N-morpholino) propanesulfonic acid-formaldehyde agarose gel. RNA was transferred overnight onto a nylon membrane in 203 saline-sodium citrate (SSC). The RNA probes for SLA-DQA and SLA-DQB were labeled with digoxigenin (DIG)-UTP using a DIG RNA Labeling kit (Roche, Indianapolis, IN). After transfer, the RNA was fixed to the blot by UV cross-linking (120 mJ). Prehybridization and hybridization were carried out at 688C using DIG Easy Hyb hybridization reagent (Roche). The blot was washed twice in lowstringency buffer (23 SSC and 0.1% SDS) for 5 min each at room temperature. The blot was then washed twice in high-stringency buffer (0.13 SSC and 0.1% SDS) for 15 min, each at 688C. After all washes, mRNA species were detected by the alkaline phosphatase reaction (Roche) and exposure to x-ray film (AgfaGevaert, Mortsel, Belgium).
Quantitative Real-Time RT-PCR
To analyze abundance of SLA-DQA and SLA-DQB mRNAs in the uterine endometrium, real-time RT-PCR was performed using the Applied Biosystems StepOnePlus System (Applied Biosystems, Foster City, CA) using the SYBR Green method. Complementary DNAs were synthesized from 4 lg of total RNA isolated from different uterine endometrial tissues, and newly synthesized cDNAs (total volume of 21 ll) were diluted 1:4 with sterile water and then used for PCR. Specific primers based on porcine SLA-DQA (GenBank accession no. NM_001130224; forward, 5 0 -GCC TAC AAG AGC TGA AGA GTG GAT GT-3 0 ; reverse, 5 0 -TGA GGG ATC AGG TAG CCG AGT G-3 0 ), SLA-DQB (GenBank accession no. NM_001113694; forward, 5 0 -CAG CGG CGA GTG CAA CCT AC-3 0 ; reverse, 5 0 -GAT GGG GTT CTG GAG GCT GG-3 0 ), and porcine ribosomal protein L7 (RPL7) (GenBank accession no. NM_001113217; forward, 5 0 -AAG CCA AGC ACT ATC ACA AGG AAT ACA-3 0 ; reverse, 5 0 -TGC AAC ACC TTT CTG ACC TTT GG-3 0 ) were designed to amplify cDNAs of 245 bp, 279 bp, and 172 bp, respectively. The Power SYBR Green PCR Master Mix (Applied Biosystems) was used for PCR reactions. Final reaction volume was 20 ll, including 2 ll of cDNA, 10 ll of 23 Master mix, 2 ll of each primer, and 4 ll of dH 2 O. PCR conditions were 958C for 15 min, followed by 40 cycles of 958C for 30 sec, 608C for 30 sec, and 728C for 30 sec. The results are reported as expression relative to that detected on Day 12 of the estrous cycle, that detected in control explant tissues, or that detected in gilts with non-SCNT conceptuses after normalization of the transcript amount to the endogenous RPL7 control by the 2 ÀDDCT method [25] .
Nonradioactive In Situ Hybridization
The nonradioactive in situ hybridization procedure was performed as described previously, with some modifications [26] . Sections (5-lm thick) were rehydrated through successive baths of xylene, 100% ethanol, 95% ethanol, diethylpyrocarbonate (DEPC)-treated water, and DEPC-treated PBS. Tissue sections were permeabilized with DEPC-treated PBS containing 0.3% Triton X-100 for 15 min. After washing in DEPC-treated PBS, they were digested using 5 lg/ml Proteinase K (Sigma) in TE (100 mM Tris-HCl, 50 mM EDTA, pH 7.5) at 378C. After postfixation in 4% paraformaldehyde, sections were incubated twice for 15 min each in PBS containing 0.1% active DEPC, and equilibrated for 15 min in 53 SSC. The sections were prehybridized for 2 h at 688C in hybridization mix (50% formamide, 53 SSC, 500 lg/ml herring sperm DNA; 200 ll on each section). Sense and antisense SLA-DQA riboprobes labeled with DIG-UTP were denatured for 5 min at 808C and added to the hybridization mix. The hybridization reaction was carried out at 688C overnight. Prehybridization and hybridization reactions were performed in a "   FIG. 3 . Immunohistochemical analysis of SLA-DQ protein in the porcine uterine endometrium during the estrous cycle and pregnancy. Immunoreactive SLA-DQ protein was localized primarily to subepithelial stromal cells and blood vessels. A tissue section from adult spleen stained with anti-SLA-DQ antibody is shown as a positive control, and a tissue section from adult liver stained with anti-SLA-DQ antibody and a tissue section from endometrium on D60 of pregnancy stained with isotype-matched normal mouse IgG served as negative controls. C, estrous cycle; CM, chorionic membrane; D, day; GE, glandular epithelial cells; LE, luminal epithelial cells; P, pregnancy; St, stroma; arrowheads, LE; arrows, SLA-DQ-immunoreactive blood vessels; asterisk, shown in inset at higher magnification. Bars ¼ 100 lm and 50 lm in inset.
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SSC at room temperature, 1 h in 23 SSC at 658C, and 1 h in 0.13 SSC at 658C. Probes bound to the section were detected immunologically using sheep anti-DIG Fab fragments covalently coupled to alkaline phosphatase and nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate (toluidine salt) as chromogenic substrate, according to the manufacturer's protocol (Roche).
Immunohistochemistry
Cell-specific expression of SLA-DQ protein in porcine endometria was determined using immunohistochemistry with 5-lm sections deparaffinized and rehydrated in an alcohol gradient. For antigen retrieval, tissue sections were treated with trypsin-0.25% EDTA for 15 min at room temperature, washed three times in PBS with 0.1% Tween-20 (PBST), and then subjected to the peroxidase block in 0.5% H 2 O 2 in methanol for 30 min. Tissue sections were then blocked with 10% normal goat serum for 30 min at room temperature. Mouse monoclonal anti-SLA-DQ antibody (BL2H5; 1:4; kindly provided from Dr. J. Dominguez, INIA, Spain) was added and incubated overnight at 48C in a humidified chamber. For each tissue tested, isotype-matched normal mouse IgG (IgG 2a ) was substituted for primary antibody and served as a negative control. Tissue sections were washed three times with PBST. The biotinylated goat antimouse secondary antibody (Vector Laboratories, Burlingame, CA) was added and incubated for 1 h at room temperature. Following washes with PBST, the streptavidin peroxidase conjugate (Zymed, San Francisco, CA) was added to the tissue sections, which were then incubated for 10 min at room temperature. The sections were washed with PBST and the 3-amino-9-ethylcarbozole in N,N-dimethylformamide color development substrate (Zymed) was added to the tissue sections, which were then incubated for 10 min at room temperature. The tissue sections were washed in water, counterstained with Mayer hematoxylin, and coverslipped.
For quantification of immunohistochemical staining signals for SLA-DQ protein, endometrial tissue sections were scanned using a TissueFAXS cytometer system (TissueGnostics, Vienna, Austria), as described previously [27] [28] [29] . Entire endometrial tissue sections, with an average of 110 fields per slide, were acquired using a 103 objective lens. Analysis of immunostaining signals was done using HistoQuest analysis software (TissueGnostics). The cutoff value for background staining was chosen using the forward/backward gating tool of the HistoQuest software. The HistoQuest analysis software measured mean relative intensity of SLA-DQ-positive immunostaining signals.
Statistical Analysis
Data from real-time RT-PCR for SLA-DQA and SLA-DQB expression during the estrous cycle and pregnancy, for hormonal effects in explant cultures, and for SLA-DQ protein histomorphometric quantification, were subjected to least-squares ANOVA using the General Linear Models procedures of SAS (Cary, NC). As sources of variation, the model included day, pregnancy status (cyclic or pregnant, Days 12 and 15 postestrus), and their interactions, to evaluate the steady-state levels of SLA-DQA and SLA-DQB mRNAs, treatment and animal to evaluate the effect of steroid hormones on SLA-DQA and SLA-DQB mRNA, and group to evaluate the effect of SCNT procedure on SLA-DQ protein. Effects of day of pregnancy (Days 12, 15, 30, 60, 90, and 114) and data from dose-response studies on SLA-DQA and SLA-DQB expression were analyzed by least-squares regression analysis. Preplanned contrasts (control vs. E 2 ; control vs. P 4 ; E 2 vs. E 2 þ P 4 ; E 2 þ P 4 vs. E 2 þ P 4 þ ICI; and E 2 þ P 4 vs. E 2 þ P 4 þ RU486 for SLA-DQA and SLA-DQB expression) were used to test for effects of treatments in the explant cultures. Data are presented as least-squares means (SEM). Data from real-time RT-PCR analysis for comparison of SLA-DQA and SLA-DQB levels in endometria with SCNT and non-SCNT embryos were subjected to the Student t-test procedure of SAS, and are presented as means (SEM).
RESULTS
Expression and Cell-Specific Localization of SLA-DQA and SLA-DQB mRNAs in Uterine Endometria During the Estrous Cycle and Pregnancy in Pigs
To determine whether SLA-DQA and SLA-DQB are expressed by cells of the porcine uterine endometrium, we cloned 524-bp partial SLA-DQA and 399-bp partial SLA-DQB cDNAs by RT-PCR. Northern blot hybridization analyses using this partial cDNAs detected SLA-DQA and SLA-DQB mRNAs as single transcripts of 1.3 kb and 1.2 kb, respectively, in total endometrial RNA from cyclic and pregnant pigs (data not shown). Results from real-time RT-PCR analysis indicated that SLA-DQA expression was affected by day, pregnancy status, and their interaction (P , 0.05; Fig. 1A ). During pregnancy, steady-state levels of SLA-DQA mRNA were highest on Day 15 and decreased thereafter (linear effect of day, P ¼ 0.069). Similarly, levels for SLA-DQB mRNA varied due to day, pregnancy status, and their interaction (P , 0.05; Fig. 1B) . Steady-state levels of SLA-DQB were highest on Day 15 and decreased thereafter (linear effect of day, P , 0.05). Expression of both SLA-DQA (Day 3 status, P , 0.01) and SLA-DQB (Day 3 status, P , 0.01) mRNAs on Day 15 of pregnancy was greater than for Day 15 of the estrous cycle.
Using in situ hybridization analysis, we determined that SLA-DQA mRNA was localized exclusively to stromal cells and blood vessels (Fig. 2) , especially subepithelial stromal cells and blood vessels on Day 15 of pregnancy. At term, SLA-DQA mRNA was barely detectable in the endometrium. SLA-DQA mRNA was also detected in adult spleen, which was used as a positive control.
Abundance and Localization of SLA-DQ Protein in the Uterine Endometria During the Estrous Cycle and Pregnancy in Pigs
Since SLA-DQA and SLA-DQB mRNAs were detected in the uterine endometrium in a stage-specific manner, we examined abundance of the proteins using immunohistochemistry. As shown in Figure 3 , SLA-DQ protein was localized mainly to subepithelial stromal cells and blood vessels as for the cellular localization as SLA-DQA mRNA. The SLA-DQ protein was detected in the uterus from early in pregnancy to term. SLA-DQ protein was also detected in adult spleen, but not in adult liver, which were used as positive and negative control tissues, respectively [30] .
Effects of Steroid Hormones IL1B and IFNG on SLA-DQA Expression in Uterine Endometrium from Day 12 of the Estrous Cycle
Because SLA-DQA and SLA-DQB expression increased significantly in the uterine endometrium on Day 15 of pregnancy, we hypothesized that E 2 , IL1B, and IFNG of conceptus origin and/or P 4 from ovarian corpora lutea might affect SLA-DQA and SLA-DQB expression. Therefore, steadystate levels of SLA-DQA and SLA-DQB mRNAs were determined for endometrial explant tissues from gilts on Day 12 of the estrous cycle that were treated with either E 2 , P 4 , E 2 þ P 4 , E 2 þ P 4 þ ICI (an estrogen receptor antagonist), E 2 þ P 4 þ RU (a progesterone receptor antagonist), or with 0, 1, 10, or 100 ng/ml of IL1B or IFNG in the presence of both E 2 and P 4 . As shown in Figure 4 , SLA-DQA and SLA-DQB mRNA levels were not affected by either P 4 or E 2 (P . 0.05; Fig. 4A ), or increasing doses of IL1B (dose, P . 0.05; Fig. 4B ). However, there was a dose-dependent effect of IFNG on the increased expression of SLA-DQA (linear effect of dose, P , 0.001) and SLA-DQB (quadratic effect of dose, P , 0.001), as shown in Figure 4C .
Analysis of SLA-DQA and SLA-DQB in Uterine Endometria Carrying Conceptuses Derived from SCNT or from Natural Mating
It was of interest to compare expression of SLA-DQ in endometria from gilts carrying either SCNT-derived conceptuses or conceptuses derived from natural mating. Endometrial KIM ET AL.
tissues associated with SCNT-derived conceptuses were evaluated in four different recipients on Day 12 of pregnancy, and in each of three different recipients with viable SCNT fetuses or with nonviable SCNT fetuses at term. On Day 12 of pregnancy, expression of SLA-DQA mRNA was not different between endometria from gilts with SCNT-derived conceptuses and endometria from gilts with conceptuses derived from natural mating (P . 0.05; Fig. 5A ), but SLA-DQB mRNA expression was lower in endometria of gilts carrying SCNTderived conceptuses on Day 12 (P , 0.05; Fig. 5B) . Interestingly, the abundance of SLA-DQ protein was less in endometria of gilts with SCNT-derived conceptuses on Day 114 of pregnancy, irrespective of viability of the fetuses (P , 0.05; Fig. 6 ). SLA-DQA and SLA-DQB mRNAs on Day 114 of pregnancy were not determined due to the poor quality of RNAs from term endometrial tissues from gilts with SCNTderived conceptuses.
DISCUSSION
Results of this study revealed that: 1) SLA-DQA and SLA-DQB were expressed in the uterine endometrium during the estrous cycle and in a stage-of-pregnancy-dependent manner; 2) SLA-DQ proteins were localized to endometrial stromal cells and blood vessels; 3) SLA-DQA and SLA-DQB expression in the uterine endometrium was regulated by IFNG of conceptus origin; and 4) SLA-DQ expression was less abundant in endometria of gilts carrying SCNT-derived conceptuses at term. This is the first report of expression of SLA-DQ in cyclic and pregnant pigs, and of the discovery that expression of SLA-DQA and SLA-DQB is regulated by IFNG in the uterine endometrium of pregnant pigs.
We reported that SLA-DQA mRNA was differentially expressed in endometria from Day 12 of pregnancy and Day 12 of the estrous cycle [14] ; however, the more sensitive and   FIG. 4 . Effects of steroid hormones (A), IL1B (B), and IFNG (C) on SLA-DQA and SLA-DQB mRNA levels in porcine endometrial explant cultures by realtime RT-PCR analysis. Endometrial explants from gilts on Day 12 of the estrous cycle were cultured in DMEM/F-12 in the presence of control (C; medium only), E 2 (E; 50 ng/ml), P 4 (P; 3 ng/ml), E 2 þ P 4 (PE), E 2 þ P 4 þ ICI (I; 200 ng/ml; an estrogen receptor antagonist) (PEI), or E 2 þ P 4 þ RU (R; 30 ng/ml, a progesterone receptor antagonist) (PER), and with 0, 1, 10, or 100 ng/ml IL1B or IFNG in the presence of both E 2 (50 ng/ml) and P 4 (3 ng/ml), at 378C for 24 h. For each treatment, all experiments were repeated in triplicate with endometria from each of three gilts. Abundance of mRNA is presented as expression relative to that for SLA-DQA and SLA-DQB mRNAs in control group of endometrial explants (medium, 0 ng/ml IL1B, or 0 ng/ml IFNG) after normalization of transcript amounts to RPL7 mRNA. Only IFNG increased expression of both SLA-DQA (linear effect of dose, P , 0.001) and SLA-DQB (quadratic effect of dose, P , 0.001). The data were analyzed using least-squares ANOVA (A) or regression analysis (B and C), and are presented as least-squares means (SEM) for relative units of expression.
SLA-DQ IN THE UTERINE ENDOMETRIUM IN PIGS
accurate method of quantitative real-time RT-PCR in the present study indicated similar expression of SLA-DQA mRNA in endometria on Day 12 of the estrous cycle and pregnancy. Interestingly, however, expression of both SLA-DQA and SLA-DQB mRNAs was significantly greater in uterine endometria on Day 15 of pregnancy than Day 15 of the estrous cycle. Furthermore, levels of SLA-DQA and SLA-DQB mRNAs were highest on Day 15 of pregnancy and decreased thereafter during pregnancy.
Pig conceptuses produce estrogens and IL1B between Days 10 and 12 of pregnancy, when conceptuses undergo rapid elongation of trophoblast from ovoid to tubular and to filamentous forms [31] [32] [33] . Estrogens produced by pig conceptuses act as the signal for maternal recognition of pregnancy [31] and affect expression of many endometrial genes, including fibroblast growth factor 7 (FGF7) [22] , secreted phosphoprotein 1 (SPP1) [34] , lysophosphatidic acid receptor 3 (LPAR3) [35] , signal transducer and activator of transcription 1 (STAT1) [36] and transient receptor potential vanilloid type 6 (TRPV6) [37] . Concentrations of IL1B protein in the uterine lumen are up to 100 ng/ml between Days 12 and 15 of pregnancy, with the highest concentrations on Day 12 of pregnancy [32] . IL1B mediates interactions between the implanting conceptus and the endometrium in mice [38] and humans [39] . Recent results indicate that IL1B induces expression of salivary lipocalin 1, a lipid-binding protein [40] . However, functions of IL1B produced by pig conceptuses are not known. Pig conceptuses also secrete two types of IFNs, IFND and IFNG, between Days 12 and 20 of pregnancy, reaching the highest levels on Days 15 and 16 of pregnancy [41, 42] . However, physiological functions of IFNs secreted by conceptuses during early pregnancy in pigs have not been established.
Increased levels of SLA-DQA and SLA-DQB mRNAs on Day 15 of pregnancy coincide with secretion of estrogens and cytokines, IL1B, IFNG, and IFND by pig conceptuses [31] . This led us to hypothesize that SLA-DQ expression is induced by estrogen, IL1B, IFNG, and IFND of conceptus origin. Indeed, results of this study revealed that only IFNG increased SLA-DQA and SLA-DQB mRNAs in a dose-dependent manner in porcine uterine endometrium. Neither estrogen nor IL1B altered expression of either SLA-DQA or SLA-DQB mRNAs. Based on evidence that MHC class II expression is not detectable in endometrial stroma on Day 15 of the estrous cycle, and that IFNG localized to uterine LE and stroma at sites of conceptus attachment [43] , results of the present study led us to conclude that IFNG of conceptus origin induces SLA-DQA and SLA-DQB mRNAs in endometria of pregnant pigs during the peri-implantation period. In addition to evidence for SLA-DQ induction by IFNG in vitro, we found differential regulation of SLA-DQA and SLA-DQB mRNAs by IFNG in endometrial explant cultures. The expression of SLA-DQA mRNA was greatest at the highest concentration of IFNG (100 ng/ml), whereas SLA-DQB mRNA expression increased at the lower concentrations of IFNG. The biological significance of differential regulation of the a and b subunits of the SLA-DQ molecule is not known. Although IFNG contributes more antiviral activity than IFND in the porcine uterine lumen [42] , IFND may also affect expression of SLA-DQ molecules. However, IFND is not currently available to test for its independent and interactive effects with IFNG.
Results of the present study indicate that SLA-DQA mRNAs and proteins are localized to subepithelial stromal cells and blood vessels. Although identification of cell types was not possible due to lack of reagents, SLA-DQ-expressing cells are likely immune cells, including macrophages, dendritic cells, various T cell populations, stromal fibroblasts, and endothelial cells, all of which express MHC class II proteins in the uterine endometrium [43] [44] [45] . MHC class II induction by IFNG has been shown in a variety of cell types, including macrophagemonocyte lineage cells, endothelial cells, epithelial cells, and stromal cells [46] [47] [48] . In the porcine uterus, IFNG receptor 1 is expressed in the endometrial epithelial cells, fibroblasts, and conceptus trophectoderm [49] , and IFNG is localized to LE and stroma underlying the conceptus at sites of implantation, but not to blood vessel and glandular epithelium [43] . These findings suggest that IFNG secreted by conceptuses binds to LE or stromal cells, but also raise the question of whether IFNG binds directly to SLA-DQ-positive cells in the stroma or induces paracrine factor(s) from LE that then induce SLA-DQ expression in subepithelial stromal cells and blood vessels. It has been suggested that tight and adherens junctions are dynamically regulated by P 4 in endometrial epithelial cells at the time of conceptus attachment in sheep to allow paracellular trafficking of molecules of conceptus and endometrial/blood origins by the epithelial junctional complexes [50] . Moreover, IFNT, a type I IFN produced by mononuclear trophectoderm cells of the elongating ruminant conceptuses, acts as the pregnancy recognition signal in ruminants. IFNT binds to both endometrial epithelial cells and stromal cells, which express type I IFN receptor subunits, IFNAR1 and IFNAR2, and differentially regulate gene expression in those cells [51] . It is likely that a similar mechanism of cellular action of IFNG occurs in the uterine endometrium in pigs, but further studies and SLA-DQB (B) mRNA levels in uterine endometria of gilts carrying conceptuses derived by SCNT (NT) as compared to that of gilts carrying conceptuses derived from natural mating (Non-NT) on Day 12 of pregnancy. Abundance of mRNA is presented as expression relative to that for SLA-DQA and SLA-DQB mRNAs in uterine endometria from gilts with non-NT conceptuses after normalization of transcript amounts to RPL7 mRNA. *Based on analysis of data using Student t-test, expression of SLA-DQB was less (P , 0.05) in endometria of gilts carrying conceptuses derived from NT on Day 12 of pregnancy. Data are presented as means (SEM).
are required to understand those cellular and molecular mechanisms for SLA-DQ induction by IFNG during the period of implantation.
MHC class II expression occurs in the uterine endometria of pigs [44, 45] and other species with human leukocyte antigen-DR, -DP, and -DQ being expressed in uterine decidua of humans during pregnancy [52, 53] . In mice, MHC class II expressed in maternal decidual macrophages during pregnancy [54] is induced by IFNG in decidua, but not in extraembryonic tissues [55] . In the bovine endometrium, caruncular macrophages express MHC class II during pregnancy [56] . Sites of placentation in canine uteri also express MHC class II molecules [57] .
Although there is MHC class II expression in the uterine endometria during pregnancy in several species, its functions are poorly understood. In pigs, SLA class II antigens function in presentation of exogenous peptides to CD4 þ helper T cells [13] , and the uterus is a part of the mucosal immune system [58] . Thus, SLA-DQ molecules likely play a protective role in case of introduction of antigenic factors from maternal tissues in close contact with the genetically disparate conceptus during pregnancy. It is also possible that SLA-DQ molecules induce immune tolerance during pregnancy through activation of CD4
þ T cells present in subepithelial layer of the endometrium during early pregnancy [42] .
The efficiency of generating viable offspring using SCNT cloning is very low [15] . In this study, SAL-DQ expression was less in the endometria of uteri carrying SCNT-derived conceptuses. During early pregnancy, SLA-DQB mRNA levels were lower in endometria of gilts carrying SCNT-derived conceptuses compared with those conceptuses derived from natural mating, and, at term, SLA-DQ proteins were less abundant in endometria from gilts carrying SCNT-derived conceptuses irrespective of viability of the fetuses. Even though function(s) of SLA-DQ molecules during pregnancy remains to be elucidated, results of the present study indicate that their expression in the endometrium is essential for maintenance of pregnancy in pigs.
In conclusion, SLA-DQ, an MHC class II molecule, is expressed in a pregnancy-dependent and cell-specific manner in response to IFNG from porcine conceptuses during the periimplantation period, and its level of expression is significantly decreased in the endometria of gilts carrying SCNT-derived conceptuses. These results provide important insights into regulation of maternal immune responses to IFNG from the developing conceptus at the maternal-fetal interface in pigs, which have a true epitheliochorial placenta.
